USE OF AN ANTIBODY AGAINST THE LAMININ RECEPTOR OR LAMININ RECEPTOR PRECURSOR FOR THE TREATMENT OR DIAGNOSIS OF SEVERAL CANCER TYPES

摘要

Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment of various cancers. Described is the use of a recombinant antibody comprising a binding site specific for an epitope of the laminin receptor or laminin receptor precursor for the treatment or diagnosis of various cancers, particularly B-CLL. Preferably, this antibody additionally comprises a binding site for at least one particular cell surface antigen.